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Prevalence of Birth Defects in Korean Livebirths, 2005-2006
We investigated the livebirths prevalence and occurrence pattern of birth defects in Korea. 
After the survey on birth defects was done in 2,348 medical institutions around the nation, 
the birth defect prevalence of livebirths in 2005-2006 was calculated. This study was based 
on the medical insurance claims database of the National Health Insurance Corporation. 
The number of livebirths in Korea was 883,184 from 2005-2006, and 25,335 cases of birth 
defects were notified to our study, equivalent to a prevalence of 286.9 per 10,000 
livebirths. Anomalies of the circulatory system were the most common defects, accounting 
for 43.4% of birth defects with a prevalence of 124.5 per 10,000 livebirths. It was 
followed by the musculoskeletal system anomalies, the digestive system anomalies, and 
the urinary system anomalies. The five major birth defects based on the ranking of 
prevalence were atrial septal defect, ventricular septal defect, hydronephrosis, patent 
ductus arteriosus, and cleft lip/palate. Birth defects in livebirths were associated with a 
high proportion of low birthweight, prematurity, multiple births and advanced maternal 
age. The prevalence of birth defects in Korea is similar to or lower than those reported in 
developed countries. Our study suggests baseline data to explain the current status of birth 
defects and to establish a registry system of birth defects in Korea.
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INTRODUCTION
 
Birth defects are defined as structural abnormalities, sensory 
changes, chromosomal abnormalities, metabolic abnormalities 
and neurodevelopmental defects that are present at birth and 
remain an important public health issue because they are a main 
cause of fetal and infant mortality and lifelong disabilities. Birth 
defects are known to occur due to single gene defects, chromo-
somal abnormalities, environmental factors and multifactorial 
causes following reciprocal effects of environmental and genet-
ic factors, but causes of 60%-70% of defects have not been de-
termined (1). Birth defects occur in 2%-3% of all births (2-5), 
and 25% of severe birth defects are multiple defects. Severe birth 
defects account for 20%-25% of perinatal mortality (2-4), and 
the prevalence of birth defects is much higher in abortion or 
stillbirth (6, 7). 
 Developed countries have examined prevalence of birth de-
fects through registration or surveillance system of fetuses and 
infants with birth defects since the 1970s and have taken effec-
tive management measures based on the collected data. In ad-
dition, establishment of international organizations have led to 
an active comparison of prevalence of major birth defects ac-
cording to countries and regions and an active search for pre-
ventive measures by sharing information. 
 In Korea, however, although medical costs for some urgent 
birth defects are financially supported considering that over 
20% of infant mortality is caused by birth defects, statistics show-
ing overall occurrence and prevalence of birth defects are still 
insufficient. Reported birth defects prevalence has varied con-
siderably, and differences may be because of racial and geo-
graphical factors, definition of birth defects, accuracy and sourc-
es of data, examination time and performance of autopsy. 
 This study aimed to elucidate the current status of birth de-
fects in Korea by investigating its prevalence and occurrence 
patterns. It is hoped the results of this study will contribute to 
the establishment and promotion of related policies and sup-
port efforts to minimize the burden caused by birth defects.
MATERIALS AND METHODS
This study was conducted by utilizing data about infants with at 
least one birth defect, delivered between 2005 and 2006, from 
the congenital anomaly survey performed by the Korea Insti-
tute for Health and Social Affairs. These data were based on the 
medical insurance claims database of the National Health In-
surance Corporation on medical institutes across the country. 
In this study, the research categories and research subjects were 
selected beforehand, and a web-based research system was op-
erated for the efficient collection of data. While the research was 
ongoing, the progress status was monitored in real time, and 
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thus, the researchers were able to respond to needs and prob-
lems that arouse at the research site. The collected data from 
the research was reviewed to make up for the weak points, and 
the data were aligned in regards to the differences or overlap in 
diagnoses between medical institutions. By adding the 2005-
2006 infant and maternal mortality survey, the birth defects prev-
alence of livebirths and stillbirths in 2005-2006 was calculated. 
As the time for diagnosis of birth defects is different according 
to disease, international birth defect surveillance organizations, 
such as the International Clearinghouse for Birth Defects Sur-
veillance and Research (ICBDSR) and the European Surveil-
lance of Congenital Anomalies (EUROCAT), have been report-
ing general statistics including diagnosis to postnatal one year. 
This study also contains the diagnosis made to postnatal one 
year. The Korean Medical Record Association reviewed the prog-
ress of investigation and directly collected the birth defects da-
tabase.
 Birth defects were categorized by birth defect group (the sys-
tem affected), subtype (the individual disease) according to the 
10th Revision of the International Classification of Diseases 
(ICD-10) and were investigated by including major groups of 
birth defects managed by EUROCAT, ICBDSR, and the National 
Birth Defects Prevention Network (NBDPN), which play lead-
ing roles internationally in this area. 
 In this study, we analyzed the medical insurance claims da-
tabase including birth defects diagnosis during the first year af-
ter birth (referring to the main disease code and sub-code) to 
obtain information regarding study subjects in advance and in-
vestigate risk factors for birth defects that could be determined 
from medical records. Most importantly, data on the same dis-
ease in the same patient from various institutions were collated 
and reviewed. The possibility that birth defects could occur in 
combination in the same patient was considered; particularly, 
birth defects of the circulatory system were classified into the 
complex disease group (a maximum of three diseases) by a pe-
diatric cardiologist. However, the major disease of the three was 
the main focus of the investigation. Because of the tendency of 
birth defects to be serious and chronic, cases of minor anoma-
lies (Q32.0, Q67.0-Q67.8, Q68.0, Q68.3-Q68.5, Q76.0, Q76.5, 
Q82.5, Q83.3, Q84.5, Q95.0, Q95.1) treated as outpatients were 
excluded.
 According to the above standards, there were 38,396 selected 
study subjects from 2,505 medical institutions. When these re-
sults were organized based on the affiliation status of the medi-
cal institutions, there were 38,199 study subjects from 2,348 
medical institutions. When reconfirmation of diagnoses, rule-
out diagnoses, and diseases name were done on the individual 
diagnosis of the study subjects, 32,727 of them were diagnosed 
with or suspected of one or more birth defects. In addition, from 
these, cases with rule-out diagnoses of birth defects and inap-
propriate cases were excluded. Moreover, since complex dis-
eases frequently arise from anomalies of the circulatory system, 
with the help of a pediatric cardiologist, the study subjects were 
categorized into complex disease groups with a maximum of 
three diseases with the main disease as the center. Therefore, 
the final number of study subjects selected for analysis from 
patients born from 2005 to 2006 was 25,335 (Fig. 1).
 As birth defects occur during intrauterine life, it is important 
to include stillbirths and abortions in birth defects statistics with 
total livebirths as a denominator. However, birth defects can be 
eliminated through spontaneous abortion in the early stage of 
pregnancy, so it is thought to be nearly impossible to determine 
a truly accurate birth defects total including abortions, stillbirth, 
and livebirths (denominator) in pregnant women for the same 
period. 
 Therefore, this study calculated livebirths prevalence of birth 
defects by dividing the number of livebirths with birth defects 
by the total number of livebirths and birth defects prevalence 
was measured with 10,000 livebirths as a standard.
Statistical analysis
We used the Poisson distribution to calculate 95% confidence 
intervals of birth defects prevalence. Variables collected for anal-
ysis were maternal and paternal age, occupation of parents, ed-
ucational background and pregnancy-related factors such as 
gestational age, birthweight, fetal gender, and plural pregnancy. 
Ethics statement
The study protocol was approved by the institutional review 
boards of Gangnam Severance Hospital (IRB No. 3-2011-0286). 
Informed consent was waived by the board. All of the data col-
lected during this study were kept confidential. 
RESULTS
The number of livebirths in Korea was 883,184 from 2005-2006, 
with 435,031 in 2005 and 448,153 in 2006. The number of infants 
with birth defects was 25,335 in 2,348 medical institutions. Base-
line demographic characteristics of total livebirths and birth 
defects in 2005-2006 are presented in Table 1. Data on paternal 
age, educational background and parents’ occupation were not 
analyzed due to high non-response rates. 
 In addition, the total number of stillbirths in 2005-2006 was 
5,079, and out of those, 640 had birth defects. Therefore, the to-
tal number of birth defects among total livebirths and stillbirths 
was 25,975 in 2005-2006. However, only the live birth prevalence 
of birth defects was analyzed in our study due to lack informa-
tion on stillbirths in our dataset.
 The prevalence of birth defects was 286.9 per 10,000 livebirths 
in 2005-2006. Anomalies of the circulatory system were the most 
common defects, accounting for 43.4% of all birth defects and 
its prevalence per 10,000 livebirths was 124.5. The next most 
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common defects were musculoskeletal system anomalies (53.1 
per 10,000 livebirths, 18.5%), digestive system anomalies (33.0 
per 10,000 livebirths, 11.5%) and urinary system anomalies (27.5 
per 10,000 livebirths, 9.6%) (Table 2). Atrial septal defect (ASD) 
was the most common birth defect of the circulatory system, 
with a prevalence of 66.6 per 10,000 livebirths. The prevalence 
of congenital hypertrophic pyloric stenosis was also high (8.6 
per 10,000 livebirths, 3.0%) among digestive system anomalies. 
The obstructive genitourinary defect was the most common 
urinary system anomaly (21.5 per 10,000 livebirths, 7.5%), fol-
lowed by congenital hydronephrosis (16.7 per 10,000 livebirths, 
5.8%) and cystic kidney (3.3 per 10,000 livebirths, 1.2%). Poly-
dactyly was the most common musculoskeletal system anoma-
ly. Its prevalence was 10.9 per 10,000 livebirths. The prevalence 
of nervous system anomalies was 9.5 per 10,000 livebirths. Spi-
na bifida was the most common birth defect of the nervous sys-
tem, with a prevalence of 2.6 per 10,000 livebirths.
 The occurrence of multiple birth defects is associated with the 
stage of embryonic development for each organ. Table 3 shows 
birth defects prevalence according to the number of birth de-
fect types involved. Prevalence of single birth defects was 235.2 
per 10,000 livebirths, accounting for 82% of all birth defects. The 
prevalence of two and three or more defects was 40.7 (14.2%) 
and 11.1 (3.9%) per 10,000 livebirths, respectively. 
 The five major birth defects based on the ranking of preva-
lence were atrial septal defect (66.6), ventricular septal defect 
(38.4), hydronephrosis (16.7), patent ductus arteriosus (14.4) 
and cleft lip/palate (11.1). In particular, the prevalences of atrial 
and ventricular septal defects were more than two times higher 
than those of other defects (Table 4).
 Birth defects in livebirths were associated with a high pro-
portion of low birthweight, prematurity, multiple births and ad-
vanced maternal age, which are high-risk populations in ma-
ternal and child health (Fig. 2). The prevalence of birth defects 
among premature infants in 2005 and 2006 tended to be 3.2 
times higher than that of infants more than 37 weeks of gesta-
tional age. The prevalence of birth defects was 1.7 times higher 
in multiple births than in singletons. The prevalence of birth de-
fects in infants with low birthweight was 3.5 times higher than 
that of normal birthweight infants. The prevalence of birth de-
Table 1. Demographic characteristics of total livebirth and birth defects in Korea, 
2005-2006
Parameters
 Total livebirths  
 (n = 883,184)
  Birth defects  
  (n = 25,335)
Maternal age (yr)  30.5 ± 5.0  30.6 ± 4.0
Gestational age (weeks)  39.0 ± 1.6  38.2 ± 2.9
Birthweight (g) 3,246 ± 455 3,069 ± 626
Fetal sex ratio (M/F)   1.08   1.28
Multiple birth (%) 2.3 3.5
Data are mean ± standard deviation or no. (%) unless otherwise specified. M, male; 
F, female.
Fig. 1. Study analysis break-
down.
Livebirths between 2005 and 2006 (Annual reports on vital statistics, Statistics Korea) 
(n = 883,184)
Birth defects referring to the main disease code or subcode 
(n = 49,985)
Exclusion of minor anomalies treated as outpatients and overlapping diagnoses 
(n = 38,398)
Organization based on the affiliation status of the medical institutions 
(n = 38,199)
Birth defects including confirmation and rule-out diagnoses 
(n = 32,727)
Final analysis excluding rule-out diagnoses 
(n = 25,335)
Infants who had a history of hospital admissions and outpatient attendances during the first year after birth 
(The medical insurance claims database of the National Health Insurance Corporation) 
(n = 376,006)
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Table 2. Prevalence of birth defect subtypes by groups in Korea, 2005-2006
Birth defects (ICD-10) Total No. of cases
Proportion (%)  
in birth defects
Prevalence per 10,000 livebirths  
[95% CI]
Nervous system (Q00-07)
   Anencephaly (Q00.0-00.2)
   Encephalocele (Q01.0-01.9)
   Microcephaly (Q02)
   Congenital Hydrocephalus (Q03.0-03.9)
   Holoprosencephaly (Q04.0-04.2)
   Spina bifida (Q05.0-05.9)
840
15
28
102
191
62
226
3.3
0.1
0.1
0.4
0.8
0.2
0.9
9.5 [8.9-10.2]
0.2 [0.08-0.3]
0.3 [0.2-0.4]
1.2 [0.9-1.4]
2.2 [1.9-2.5]
0.7 [0.5-0.9]
2.6 [2.2-2.9]
Eye, ear, face and neck (Q10-18)
   Anophthalmos (Q11.0-Q11.1)
   Microphthalmos (Q11.2)
   Congenital cataract (Q12.0)
   Aniridia (Q13.1)
   Congenital graucoma (Q15.0)
   Anotia (Q16.0)
   Microtia (Q17.2)
2,267
5
32
121
9
44
16
126
8.9 
0.02
0.1
0.5
0.04
0.2
0.1
0.5
25.7 [24.6-26.7]
0.06 [0.01-0.1]
0.4 [0.2-0.5]
1.4 [1.1-1.6]
0.1 [0.04-0.2]
0.5 [0.4-0.7]
0.2 [0.09-0.3]
1.4 [1.2-1.7]
Circulatory system (Q20-28)
   Transposition of great arteries (Q20.3)
   Single ventricle (Q20.4)
   Ventricular septal defect (Q21.0)
   Atrial septal defect (Q21.1)
   Tetralogy of Fallot (Q21.3)
   Pulmonary valve atresia/stenosis (Q22.0-22.1)
   Patent ductus arteriosus (Q25.0)*
   Coarctation of aorta (Q25.1)
10,997
139
29
3,388
5,880
371
430
1,274
222
43.4
0.5
0.1
13.4
23.2
1.5
1.7
5.0
0.9
124.5 [122.2-126.8]
1.6 [1.3-1.8]
0.3 [0.2-0.5]
38.4 [37.1-39.7]
66.6 [64.9-68.3]
4.2 [3.8-4.6]
4.9 [4.4-5.3]
14.4 [13.6-15.2]
2.5 [2.2-2.8]
Respiratory system (Q30-34)
   Choanal atresia (Q30.0)
515
22
2.0
0.1
5.8 [5.3-6.3]
0.3 [0.2-0.4]
Cleft lip/palate (Q35-37) 980 3.9 11.1 [10.4-11.8]
Digestive system (Q38-45)
   Esophageal atresia/stenosis (Q39.0-39.1)
   Congenital hypertrophic pyloric stenosis (Q40.0)
   Duodenal atresia/stenosis (Q41.0)
   Small intestine atresia/stenosis (Q41.0-41.9)
   Anorectal atresia/stenosis (Q42.0-42.3)
   Congenital megacolon (Q43.1)
   Atresia of bile duct (Q44.2)
2,910
111
761
72
189
321
454
128
11.5 
0.4
3.0
0.3
0.7
1.3
1.8
0.5
33.0 [31.8-34.1]
1.3 [1.0-1.5]
8.6 [8.0-9.2]
0.8 [0.6-1.0]
2.1 [1.8-2.5]
3.6 [3.2-4.0]
5.1 [4.7-5.6]
1.5 [1.2-1.7]
Genital organs (Q50-56)
   Undescended testis (Q53.0-53.9)†
   Hypospadias (Q54.0-54.9)
   Indeterminate sex (Q56.0-56.4)
1,541
966
315
59
6.1 
3.8
1.2
0.2
17.5 [16.6-18.3]
10.9 [10.3-11.6]
3.6 [3.2-4.0]
0.7 [0.5-0.8]
Urinary system (Q60-64)
   Renal agenesis (Q60.0-60.6)
   Renal dysplasia (Q61.4)
   Cystic kidney (Q61.0-61.9)
   Congenital hydronephrosis (Q62.0)
   Obstructive genitourinary defect (Q62.0-62.8, Q64.3)
2,426
129
65
294
1,477
1,897
9.6
0.5
0.3
1.2
5.8
7.5
27.5 [26.4-28.6]
1.5 [1.2-1.7]
0.7 [0.6-0.9]
3.3 [3.0-3.7]
16.7 [15.9-17.6]
21.5 [20.5-22.4]
Musculoskeletal system (Q65-79)
   Congenital hip dislocation (Q65.0-65.9)
   Club foot-talipes equinovarus (66.0)
   Polydactyly (Q69.0-69.9)
   Syndactyly (Q70.0-70.9)
   Total limb reduction defects (Q71.0-71.9, Q72.0-72.9, Q73.0-73.8)
   Arthrogryposis multiplex congenita (Q74.3)
   Craniosynostosis (Q75.0)
   Achondroplasia/hypochondroplasia (Q77.4)
   Diaphragmatic hernia (Q79.0)
   Omphalocele (Q79.2)
   Gastroschisis (Q79.3)
4,685
764
120
958
461
88
29
167
27
106
55
22
18.5
3.0
0.5
3.8
1.8
0.3
0.1
0.7
0.1
0.4
0.2
0.1
53.1 [51.5-54.6]
8.7 [8.0-9.3]
1.4 [1.1-1.6]
10.9 [10.2-11.5]
5.2 [4.7-5.7]
1.0 [0.8-1.2]
0.3 [0.2-0.5]
1.9 [1.6-2.2]
0.3 [0.2-0.4]
1.2 [1.0-1.4]
0.6 [0.5-0.8]
0.3 [0.2-0.4]
Other and unspecified (Q80-89) 786 3.1 8.9 [8.3-9.5]
Chromosomal abnormalities (Q90-99) 557 2.2 6.3 [5.8-6.8]
Total 25,335 100 286.9 [283.4-290.3]
*Patent ductus arteriosus was excluded if birthweight was less than 2,500 g; †Undescended testis was excluded if gestational age was less than 36 weeks. ICD, International 
classification of diseases, 10th revision; CI, confidence interval.
Kim M-A, et al. • Prevalence of Birth Defects in Korea
http://jkms.org  1237http://dx.doi.org/10.3346/jkms.2012.27.10.1233
alies and chromosomal abnormalities between maternal age 
35 yr or older and less than 35 yr. Also, our study indicated that 
all birth defect groups was associated with preterm delivery 
(Table 5). 
 The prevalence of chromosomal anomalies was 6.3 per 10,000 
livebirths in 2005-2006. Down syndrome was the most common 
chromosomal anomaly and its prevalence was 3.7 per 10,000 
Table 4. Prevalence of major birth defect subtypes in Korea, 2005-2006
Birth defect subtypes
Total No.  
of cases
Proportion (%) 
in birth  
defects
Prevalence per 
10,000 live birth  
[95% CI]
ASD 5,880 23.2  66.6 [64.9-68.3]
VSD 3,388 13.4  38.4 [37.1-39.7]
Hydronephrosis 1,477 5.8  16.7 [15.9-17.6]
PDA* 1,274 5.0  14.4 [13.6-15.2]
Cleft lip/palate 980 3.9  11.1 [10.4-11.8]
Undescended testis† 966 3.8  10.9 [10.3-11.6]
Polydactyly 958 3.8  10.9 [10.2-11.5]
Hip dislocation 764 3.0 8.7 [8.0-9.3]
Syndactyly 461 1.8 5.2 [4.7-5.7]
Megacolon 454 1.8 5.1 [4.7-5.6]
Pulmonary valve 430 1.7 4.9 [4.4-5.3]
Atresia and stenosis
TOF 371 1.5 4.2 [3.8-4.6]
Down syndrome 327 1.3 3.7 [3.3-4.1]
Anorectal atresia/stenosis 321 1.3 3.6 [3.2-4.0]
Hypospadias 315 1.2 3.6 [3.2-4.0]
Cystic kidney 294 1.2 3.3 [3.0-3.7]
Spina bifida 226 0.9 2.6 [2.2-2.9]
CoA 222 0.9 2.5 [2.2-2.8]
Hydrocephalus 191 0.8 2.2 [1.9-2.5]
Small intestine atresia/stenosis 189 0.7 2.1 [1.8-2.5]
*Patent ductus arteriosus was excluded if birth weight was less than 2,500 g; †Unde-
scended testis was excluded if gestational age was less than 36 weeks. CI, confidence 
interval; ASD, atrial septal defect; VSD, ventricular septal defect; PDA, patent ductus 
arteriosus; TOF, tetralogy of Fallot; CoA, coarctation of aorta.
Table 3. Prevalence of birth defects according to the number of different birth defect 
groups involved
Number of birth  
defect groups involved
Total No.  
of cases
Proportion (%)  
in birth defects
Prevalence per 10,000 
livebirths [95% CI]
1 20,768 82.0   235.2 [232.0-238.3]
2   3,591 14.2 40.7 [39.3-42.0]
3 or more      976   3.9 11.1 [10.4-11.7]
CI, confidence interval.
Table 5. Prevalence of birth defect groups in Korea, 2005-2006
Birth defect groups (ICD-10)
Maternal age Gestational age
< 35 yr ≥ 35 yr P value ≥ 37 weeks < 37 weeks P value
Nervous system (Q00-07) 8.8 9.3 0.606 7.0 49.8 < 0.001
Eye, ear, face and neck (Q10-18) 24.4 25.6 0.436 22.4 41.4 < 0.001
Circulatory system (Q20-28) 116.8 133.5 < 0.001 100.8 431.8 < 0.001
Respiratory system (Q30-34) 5.6 6.1 0.437 4.4 29.3 < 0.001
Cleft lip/ palate (Q35-37) 10.5 10.8 0.779 9.7 20.5 < 0.001
Digestive system (Q38-45) 31.6 30.6 0.579 28.1 93.3 < 0.001
Genital organs (Q50-56) 16.7 17.1 0.736 15.2 35.4 < 0.001
Urinary system (Q60-64) 26.2 27.4 0.452 24.3 71.2 < 0.001
Musculoskeletal system (Q65-79) 50.9 50.9 0.967 46.0 103.5 < 0.001
Other and unspecified (Q80-89) 8.5 9.3 0.37 7.9 21.2 < 0.001
Chromosomal abnormalities (Q90-99) 4.7 11.9 < 0.001 4.8 27.0 < 0.001
ICD, International classification of diseases, 10th revision.
fects according to maternal age was 1.1 times higher in mothers 
≥ 35 yr of age than in mothers < 35 yr of age. There were signif-
icant differences in the prevalence of circulatory system anom-
Table 6. Prevalence of major chromosomal anomalies in Korea, 2005-2006
Chromosomal birth defects 
Total No. 
of cases
% in birth  
defects
Prevalence per 10,000 
livebirths [95% CI]
Trisomy 13     6 0.02 0.07 [0.01-0.1]
Trisomy 18   20 0.08 0.2 [0.1-0.3]
Down’s syndrome 327 1.29 3.7 [3.3-4.1]
Turner’s syndrome   24 0.09 0.3 [0.2-0.4]
Kleinfelter’s syndrome   10 0.04   0.1 [0.04-0.2]
Wolff-Hirschorn syndrome     3 0.01   0.03 [0.00-0.07]
Cri-du-chat syndrome   12 0.05   0.1 [0.06-0.2]
Other chromosomal anomalies 155 0.61   1.8 [1.5, 2.03]
CI, confidence interval.
Fig. 2. Proportion of birth defects according to birthweight, gestational age, maternal 
age, and plurality in Korea, 2005-2006. BW, birthweight; GW, gestational weeks.
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livebirths, accounting for 1.3% of all birth defects (Table 6). 
 The prevalence of birth defects in Korea was similar to or 
somewhat lower than those of the compared countries (Table 
7). Down syndrome prevalence (3.7 per 10,000 livebirths) in 
Korea was especially lower than in Japan (10.57 per 10,000 live-
births) and the United States (13.56 per 10,000 livebirths), which 
may reflect terminations of pregnancy after prenatal diagnosis 
of Down syndrome.
DISCUSSION
Since the importance of birth defects was recognized in the 
1960s, studies have been done to determine its prevalence. How-
ever, since most of the studies were limited to a single institute 
or region and not nationwide, birth defects prevalence varied 
widely from 0.5% to 6.8% (8, 9). In this study, we investigated the 
prevalence and occurrence pattern of birth defects in Korea.
 The reported frequency of birth defects has been 2%-3% (2-
5). The prevalence of birth defects in Korea found in this study 
was 286.9 per 10,000 livebirths, which was similar to previous 
studies. Among all birth defects studied, the prevalence of circu-
latory system anomalies was 124.5 per 10,000 livebirths (43.4%) 
followed by anomalies of the musculoskeletal system, digestive 
system, and urinary system. Kang et al. (8) reported the preva-
lence of birth defects was highest in the genitourinary system 
followed by the central nervous and digestive system. McIntosh 
et al. (10) reported the order to be the musculoskeletal, integu-
mentary, and central nervous system, while Hong et al. (11) re-
ported the order to be the musculoskeletal, digestive, and geni-
tourinary system. The fact that reported frequencies vary may 
be due to the variety and subjectivity of classification criteria, 
whether or not autopsy was carried out, and differences in di-
agnostic ability. It is generally considered that the proportion of 
multiple birth defects is 20%-30% (12), but the proportion was 
18.0% in this study.
 We compared Korean birth defects prevalence with that of 
countries that reported data produced under similar criteria 
through ICBDSR and NBDPN, and the results showed that it 
was similar to or lower than those of the compared countries. 
The prevalence of Down syndrome was particularly low in Ko-
rea, which may be because of terminations of pregnancy after 
prenatal diagnosis. The prevalence of cleft lip/palate was simi-
lar to or somewhat lower than that of the compared countries 
(13-15).
 The difference in statistical reports of birth defects frequency 
is due to differences in race, environmental factors, data col-
lecting methods, time and method of birth defects diagnosis, 
whether or not autopsy was carried out after death of the new-
born infants, and so on. In particular, it is assumed that many of 
the internal birth defects that can be discovered by means of 
autopsy are missed since autopsies of stillborn infants are per-
formed less frequently in Korea than in other countries.
 According to our study, the prevalence of birth defects was 
higher in high-risk populations of the maternal and child health, 
such as low birthweight, prematurity, multiple births and ad-
vanced maternal age. The relationship between maternal age 
and the prevalence of birth defects has been discussed in sev-
eral studies. Schull (16) reported that the prevalence of birth 
defects increased as maternal age increased and, especially, the 
occurrence of Down syndrome was closely related to advanced 
maternal age. Hook (17) reported that the prevalence of signifi-
cant cytogenetic abnormalities increased with maternal age 
and significantly contribute to the overall rate at the older ages. 
Although high-risk pregnancy is not determined only by mater-
nal age, maternal age is significant because the prevalence of 
chronic diseases increases as maternal age increases.
 Additionally, our study showed that the prevalence of birth 
defects was high in cases where the birthweight was less than 
2,500 g or the gestation age was less than 37 weeks. The preva-
lence of birth defects among low birthweight and normal birth-
weight infants was 8.7% and 2.4%, respectively, indicating that 
the frequency was higher in low birthweight infants. This result 
is in line with the results of two previous studies conducted by 
Choi et al. and Park and Lee, respectively (18, 19). In the former 
study, the prevalence of birth defects among low birthweight 
and normal birthweight infants was 1.9% and 0.5% while it was 
8.14% and 1.62% in the latter study.
 Based on this result, it is assumed that the high prevalence 
may also be related to intrauterine growth retardation and pre-
term birth caused by birth defects. In addition, Tanner et al. (20) 
reported that the risk of congenital heart defect was 2.4 times 
higher in premature infants than in mature infants. Purisch et 
al. (21) reported that the risk of childbirth at the 35th week or 
before was 3.2 times higher and the risk of childbirth at the 28th 
Table 7. Prevalence of selected birth defects in Korea, Japan and the United States
Birth defects
Prevalence per 10,000 livebirths
Korea,  
2005-2006
Japan,  
2005-2006*
United States, 
2004-2006†
Anencephaly 0.17 0.47 2.06
Spina bifida 2.56 4.47 3.5
Encephalocele 0.32 0.75 0.82
Transposition of great arteries 1.57 4.2 3.0
Tetralogy of fallot 4.2 5.76 3.97
Cleft lip/palate 11.1 12.54 8.49
Esophageal atresia/stenosis 1.26 4.34 2.17
Diaphragmatic hernia 1.2 5.22 2.61
Omphalocele 0.62 2.98 1.86
Gastroschisis 0.25 2.3 4.49
Trisomy 13 0.07 1.42 1.28
Trisomy 18 0.23 4.81 2.64
Down syndrome 3.7 10.57 13.56
*Data from International Clearinghouse for Birth Defect Surveillance and Research 
(ICBDSR); †Data from National Birth Defects Prevention Network (NBDPN).
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week or before was 4.8 times higher in the infants with birth de-
fects.
 However, this result only means that the prevalence of birth 
defects is highly related to the variables, but it does not mean 
that low birthweight or preterm birth is the cause of birth de-
fects. Since the causes of low birthweight infants are similar to 
the causes of birth defects in general, it is reported that birth 
defects are highly related to the occurrence of low birthweight 
infants.
 With respect to sex, the probability of birth defects is higher 
in males than in females in this study. Similarly, Marden et al. 
(4) showed the ratio of male to female infants was 58:42; and 
the ratio was 61:39 in the study by McIntosh et al. (10).
 Systematic data gath ering and monitoring of birth defects 
started in 1958 in Birmingham, United Kingdom (22). Since 
then, the interest in birth defects has elevated worldwide: EU-
ROCAT was founded and is working in Europe (23), and an ex-
tensive monitoring of birth defects has been carried out in the 
United States mainly by the Centers for Diseases Control and 
Prevention and other public health authorities in each state (12). 
On the contrary, a comprehensive monitoring system has not 
been established in Korea, not only on the national scale but also 
on the local scale. Although international monitoring of birth 
defects is actively performed as an effort not only to improve 
quality of life but also to reduce disease burden, Korea has not 
yet participated since the system to produce statistical data has 
not been established. Since birth defects are particularly affect-
ed by changes in the environment, international cooperation is 
required for effective prevention and management.
 In this study, statistical analysis was not accurately carried 
out because it was focused on parturient women who had de-
livered infants with birth defects, and thus the comparison with 
parturient women who have delivered normal infants was not 
performed well. In addition, a careful analysis of medicine tak-
en during pregnancy, mothers’ occupation and living environ-
ment is required to investigate the correlation between envi-
ronmental factors and birth defects, but most of the data lacked 
detailed records. Therefore, future studies are needed to make a 
more accurate and objective analysis.
 Birth defects are the frequent cause of spontaneous abortion 
and death of newborn infants and are one of the three major 
causes of death in the perinatal period in addition to premature 
birth and birth injury (6). The proportion of birth defects in cas-
es of death in the perinatal period will increase due to the de-
velopment of intensive care for newborn infants. It is necessary 
to produce data periodically so that trends can be monitored for 
effective prevention and management of birth defects. This study 
is a nationwide investigation of birth defects in Korea which sug-
gests baseline data to be helpful in understanding the current 
status of birth defects and in monitoring the occurrence pattern 
of birth defects. 
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